Seshadri Neervannan, Chief Operating Officer at Tarsus Pharmaceuticals, Inc. (TARS), sold 15,166 shares at $46.29 ($726K) on 2025-03-18, disclosed to the SEC on 2025-03-20.
Open-market sale of $726k TARS by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.29 | 2,605 | $121K | 16.6% |
| 2 | $46.29 | 2,605 | $121K | 16.6% |
| 3 | $47.40 | 2,543 | $121K | 16.6% |
| 4 | $47.40 | 2,543 | $121K | 16.6% |
| 5 | $50.11 | 2,435 | $122K | 16.8% |
| 6 | $50.11 | 2,435 |
| $122K |
| 16.8% |
| Total | $47.89 avg | 15,166 | $726K | 100% |
| Filing → |
| TARS | SELL | 2026-03-19 | $772K | — | Filing → |
| TARS | SELL | 2026-03-05 | $641K | — | Filing → |
| TARS | SELL | 2024-03-19 | $299K | — | Filing → |